Friday, August 22, 2008

More Doubts About HPV Vaccines

Tim Waggoner reports for LifeSiteNews that this week's edition of the New England Journal of Medicine contains articles critical of two human papillomavirus vaccines: Gardasil and Cervarix. The articles point out the drugs' high costs, "unproven effectiveness," and other problems.

This is definitely not good news for the manufacturers, Gardasil's Merck Sharp & Dohme (already under fire for the terrible side-effects created by the drug, side-effects that have killed 21 women) and Cervarix's GlaxoSmithKline.

But it is good news for America's young women whose lives and health are being endangered by powerful, costly and woefully undertested drugs. Bad publicity will cause more doctors to stay away from recommending the vaccines...and more women to refuse to trust the drug even when it is offered.

And who knows -- perhaps the truths emerging about these drugs might even provoke a thoughtful reconsideration by women (and, in the case of the very young, their parents) of the extreme dangers involved in casual sex.

The safe, eminently sane choice of a chaste lifestyle is back in vogue, in part, due to the ugly, heartbreaking and physically perilous repercussions from the alternative.